A single-center cohort study of patients with hereditary spherocytosis in Central Europe reveals a high frequency of novel disease-causing genotypes
- PMID: 38434532
- PMCID: PMC10878193
- DOI: 10.1002/hem3.31
A single-center cohort study of patients with hereditary spherocytosis in Central Europe reveals a high frequency of novel disease-causing genotypes
Conflict of interest statement
Leo Kager reports acting on the advisory board of Agios, Amgen, Bayer, and Novartis (unrelated to this study). The remaining authors declare no conflict of interest.
Figures
References
LinkOut - more resources
Full Text Sources